These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38666508)

  • 21. A Feasibility Study of [
    Shrestha UM; Chae HD; Fang Q; Lee RJ; Packiasamy J; Huynh L; Blecha J; Huynh TL; VanBrocklin HF; Levi J; Seo Y
    Mol Imaging Biol; 2024 Oct; 26(5):869-878. PubMed ID: 39060882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. F-18 sodium fluoride PET/CT does not effectively image myocardial inflammation due to suspected cardiac sarcoidosis.
    Weinberg RL; Morgenstern R; DeLuca A; Chen J; Bokhari S
    J Nucl Cardiol; 2017 Dec; 24(6):2015-2018. PubMed ID: 27197820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of Cardiac Sarcoidosis: FDG PET and BMIPP SPECT.
    Campisi R; Merani MF; Rodríguez MI
    Curr Cardiol Rep; 2022 Dec; 24(12):1873-1882. PubMed ID: 36282434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infectious Myocarditis on FDG-PET Imaging Mimicking Sarcoidosis.
    Sperry BW; Oldan JD; Hsich EM; Reynolds JP; Tamarappoo BK
    J Nucl Cardiol; 2015 Aug; 22(4):840-4. PubMed ID: 25968627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematically evaluating DOTATATE and FDG as PET immuno-imaging tracers of cardiovascular inflammation.
    Toner YC; Ghotbi AA; Naidu S; Sakurai K; van Leent MMT; Jordan S; Ordikhani F; Amadori L; Sofias AM; Fisher EL; Maier A; Sullivan N; Munitz J; Senders ML; Mason C; Reiner T; Soultanidis G; Tarkin JM; Rudd JHF; Giannarelli C; Ochando J; Pérez-Medina C; Kjaer A; Mulder WJM; Fayad ZA; Calcagno C
    Sci Rep; 2022 Apr; 12(1):6185. PubMed ID: 35418569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of 18F fluorodeoxyglucose positron emission tomography (18F-FDG-PET) in children with rheumatic carditis and chronic rheumatic heart disease.
    Nagesh CM; Saxena A; Patel C; Karunanithi S; Nadig M; Malhotra A
    Nucl Med Rev Cent East Eur; 2015; 18(1):25-8. PubMed ID: 25633513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significant suppression of myocardial (18)F-fluorodeoxyglucose uptake using 24-h carbohydrate restriction and a low-carbohydrate, high-fat diet.
    Kobayashi Y; Kumita S; Fukushima Y; Ishihara K; Suda M; Sakurai M
    J Cardiol; 2013 Nov; 62(5):314-9. PubMed ID: 23810066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2-deoxy-2-[
    Mannes PZ; Barnes CE; Latoche JD; Day KE; Nedrow JR; Lee JS; Tavakoli S
    Mol Imaging Biol; 2023 Aug; 25(4):681-691. PubMed ID: 36941514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic performance of
    Ko WS; Kim SJ
    Hell J Nucl Med; 2023; 26(2):132-139. PubMed ID: 37527049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; A systematic review and meta-analysis.
    Kim SJ; Pak K; Kim K
    J Nucl Cardiol; 2020 Dec; 27(6):2103-2115. PubMed ID: 30603894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of myocardial washout of
    Suzuki M; Izawa Y; Fujita H; Miwa K; Takahashi Y; Toh H; Toba T; Fujiwara S; Hashimura H; Kono AK; Hirata KI
    Ann Nucl Med; 2022 Jun; 36(6):544-552. PubMed ID: 35303274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 18F-FDG PET-Based Imaging of Myocardial Inflammation Predicts a Functional Outcome Following Transplantation of mESC-Derived Cardiac Induced Cells in a Mouse Model of Myocardial Infarction.
    Vasudevan P; Gaebel R; Doering P; Mueller P; Lemcke H; Stenzel J; Lindner T; Kurth J; Steinhoff G; Vollmar B; Krause BJ; Ince H; David R; Lang CI
    Cells; 2019 Dec; 8(12):. PubMed ID: 31835854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
    Dweck MR; Abgral R; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Palmisano A; Miller MA; Lala A; Chang HL; Sanz J; Contreras J; Narula J; Fuster V; Padilla M; Fayad ZA; Kovacic JC
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):94-107. PubMed ID: 28624396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of (
    Pan L; Zhang F; Ran Y; Bi L; Jin H; Yao L
    Diagn Interv Radiol; 2023 May; 29(3):548-554. PubMed ID: 37154799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging proliferation in human leukemia-tumor bearing mice with (18)F-FLT: Comparison with (18)F-FDG PET.
    Lu L; Jiang L; Guan H; Gao Y; Lu H
    Hell J Nucl Med; 2012; 15(3):206-9. PubMed ID: 23106052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.
    Greulich S; Gatidis S; Gräni C; Blankstein R; Glatthaar A; Mezger K; Müller KAL; Castor T; Mahrholdt H; Häntschel M; Hetzel J; Dittmann H; Nikolaou K; Gawaz M; la Fougère C; Krumm P
    JACC Cardiovasc Imaging; 2022 Mar; 15(3):445-456. PubMed ID: 34656480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. (18)F-alfatide II and (18)F-FDG dual-tracer dynamic PET for parametric, early prediction of tumor response to therapy.
    Guo J; Guo N; Lang L; Kiesewetter DO; Xie Q; Li Q; Eden HS; Niu G; Chen X
    J Nucl Med; 2014 Jan; 55(1):154-60. PubMed ID: 24232871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocarditis with high
    Norikane T; Yamamoto Y; Noma T; Nishiyama Y
    J Nucl Cardiol; 2018 Apr; 25(2):691-692. PubMed ID: 28852983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-carbohydrate diet versus euglycemic hyperinsulinemic clamp for the assessment of myocardial viability with 18F-fluorodeoxyglucose-PET: a pilot study.
    Soares J; Rodrigues Filho F; Izaki M; Giorgi MC; Catapirra RM; Abe R; Vinagre CG; Cerri GG; Meneghetti JC
    Int J Cardiovasc Imaging; 2014 Feb; 30(2):415-23. PubMed ID: 24253855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer immunotherapy is accompanied by distinct metabolic patterns in primary and secondary lymphoid organs observed by non-invasive
    Schwenck J; Schörg B; Fiz F; Sonanini D; Forschner A; Eigentler T; Weide B; Martella M; Gonzalez-Menendez I; Campi C; Sambuceti G; Seith F; Quintanilla-Martinez L; Garbe C; Pfannenberg C; Röcken M; la Fougere C; Pichler BJ; Kneilling M
    Theranostics; 2020; 10(2):925-937. PubMed ID: 31903160
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.